Characterization of the anticholinergic properties of obidoxime; functional examinations of the rat atria and the urinary bladder

References

• Bajgar J. 2004. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151–216.
   PubMed Web of Science ®Google Scholar
• Benhaim SA, Benami H, Hayam G, Taitelman U, Edoute Y. 1992. Obidoxime augments the positive inotropic effect of phosphamidon on the isolated working rat-heart. Pharmacol Toxic 71:127–131.
   PubMedGoogle Scholar
• Broadley KJ, Kelly DR. 2001. Muscarinic receptor agonists and antagonists. Molecules 6:142–193.
   Web of Science ®Google Scholar
• Broadley KJ, Lumley P. 1977. Selective reserpine-induced supersensitivity of positive inotropic and chronotropic responses to isoprenaline and salbutamol in guinea-pig isolated atria. Brit J Pharmacol 59:51–60.
   PubMed Web of Science ®Google Scholar
• Bymaster FP, Carter PA, Zhang L, Falcone JF, Stengel PW, Cohen ML, Shannon HE, Gomeza J, Wess J, Felder CC. 2001. Investigations into the physiological role of muscarinic M-2 and M-4 muscarinic and M-4 receptor subtypes using receptor knockout mice. Life Sci 68:2473–2479.
   PubMed Web of Science ®Google Scholar
• Caulfield MP, Birdsall NJM. 1998. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279–290.
   PubMed Web of Science ®Google Scholar
• Ellis J, Seidenberg M. 1992. 2 Allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol Pharmacol 42:638–641.
   PubMed Web of Science ®Google Scholar
• Giglio D, Aronsson P, Eriksson L, Tobin G. 2007. In vitro characterization of parasympathetic and sympathetic responses in cyclophosphamide-induced cystitis in the rat. Basic Clin Pharmacol Toxicol 100:96–108.
   PubMed Web of Science ®Google Scholar
• Giglio D, Delbro DS, Tobin G. 2001. On the functional role of muscarinic M-2 receptors in cholinergic and purinergic responses in the rat urinary bladder. Eur J Pharmacol 428:357–364.
   PubMed Web of Science ®Google Scholar
• Gnagey A, Ellis J. 1996. Allosteric regulation of the binding of H-3 acetylcholine to m2 muscarinic receptors. Biochem Pharmacol 52:1767–1775.
   PubMed Web of Science ®Google Scholar
• Grossmuller M, Antony J, Trankle C, Holzgrabe U, Mohr K. 2006. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist. Naunyn Schmiedebergs Arch Pharmacol 372:267–276.
   PubMed Web of Science ®Google Scholar
• Hamilton MG, Lundy PM. 1989. HI-6 therapy of soman and tabun poisoning in primates and rodents. Arch Toxicol 63:144–149.
   PubMed Web of Science ®Google Scholar
• Hegde SS, Choppin A, Bonhaus D, Briaud S, Loeb M, Moy TM, Loury D, Eglen RM. 1997. Functional role of M-2 and M-3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Brit J Pharmacol 120:1409–1418.
   PubMed Web of Science ®Google Scholar
• Kassa J. 2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803–816.
   PubMed Web of Science ®Google Scholar
• Kuca K, Patocka J, Cabal J, Jun D. 2004. Reactivation of organophosphate-inhibited acetylcholinesterase by quaternary pyridinium aldoximes. Neurotox Res 6:565–570.
   PubMed Web of Science ®Google Scholar
• Lee NH, Elfakahany EE. 1991. Allosteric antagonists of the muscarinic acetylcholine-receptor. Biochem Pharmacol 42:199–205.
   PubMed Web of Science ®Google Scholar
• Longhurst PA, Leggett RE, Briscoe JAK. 1995. Characterization of the functional muscarinic receptors in the rat urinary-bladder. Br J Pharmacol 116:2279–2285.
   PubMed Web of Science ®Google Scholar
• Marrs TC. 1993. Organophosphate poisoning. Pharmacol Ther 58:51–66.
   PubMed Web of Science ®Google Scholar
• Melchiorre C, Cassinelli A, Quaglia W. 1987. Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines - novel class of selective antagonists of cardiac M-2 muscarinic receptors. J Med Chem 30:201–204.
   PubMed Web of Science ®Google Scholar
• Proska J, Tucek S. 1995. Competition between positive and negative allosteric effectors on muscarinic receptors. Mol Pharmacol 48:696–702.
   PubMed Web of Science ®Google Scholar
• Saleh TM, Saleh MC, Connell BJ. 2001. Estrogen blocks the cardiovascular and autonomic changes following vagal stimulation in ovariectomized rats. Autonomic Neurosci Basic Clin 88:25–35.
   PubMed Web of Science ®Google Scholar
• Tattersall JE. 1993. Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro. Br J Pharmacol 108:1006–1015.
   PubMed Web of Science ®Google Scholar
• Tobin G, Sjogren C. 1995. In-vivo and in-vitro effects of muscarinic receptor antagonists on contractions and release of H-3 acetylcholine in the rabbit urinary-bladder. Eur J Pharmacol 281:1–8.
   PubMed Web of Science ®Google Scholar
• Trankle C, Dittmann A, Schulz U, Weyand O, Buller S, Johren K, Heller E, Birdsall NJ, Holzgrabe U, Ellis J, Holtje HD, Mohr K. 2005. Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors. Mol Pharmacol 68:1597–1610.
   PubMed Web of Science ®Google Scholar
• Van Helden HP, Busker RW, Melchers BP, Bruijnzeel PL. 1996. Pharmacological effects of oximes: how relevant are they? Arch Toxicol 70:779–786.
   PubMed Web of Science ®Google Scholar
• Vanhelden HPM, Vanderwiel HJ, Delange J, Busker RW, Melchers BPC, Wolthuis OL. 1992. Therapeutic efficacy of Hi-6 in soman-poisoned marmoset monkeys. Toxicol Appl Pharmacol 115:50–56.
   PubMed Web of Science ®Google Scholar
• Worek F, Backer M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P. 1997. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol 16:466–472.
   PubMed Web of Science ®Google Scholar
• Worek F, Widmann R, Knopff O, Szinicz L. 1998. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLo 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 72:237–243.
   PubMed Web of Science ®Google Scholar